10-60196628-GAAA-GAAAAA
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_020987.5(ANK3):c.1690-5_1690-4dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00653 in 1,247,256 control chromosomes in the GnomAD database, including 51 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 43 hom., cov: 28)
Exomes 𝑓: 0.0058 ( 8 hom. )
Consequence
ANK3
NM_020987.5 splice_region, intron
NM_020987.5 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.469
Publications
5 publications found
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
- intellectual disability-hypotonia-spasticity-sleep disorder syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- intellectual disabilityInheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 10-60196628-G-GAA is Benign according to our data. Variant chr10-60196628-G-GAA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.013 (1728/133102) while in subpopulation AFR AF = 0.0433 (1609/37128). AF 95% confidence interval is 0.0416. There are 43 homozygotes in GnomAd4. There are 814 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AR,Unknown,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ANK3 | NM_020987.5 | c.1690-5_1690-4dupTT | splice_region_variant, intron_variant | Intron 14 of 43 | ENST00000280772.7 | NP_066267.2 | ||
| ANK3 | NM_001204404.2 | c.1639-5_1639-4dupTT | splice_region_variant, intron_variant | Intron 14 of 43 | NP_001191333.1 | |||
| ANK3 | NM_001320874.2 | c.1690-5_1690-4dupTT | splice_region_variant, intron_variant | Intron 14 of 42 | NP_001307803.1 | |||
| ANK3 | NM_001204403.2 | c.1672-5_1672-4dupTT | splice_region_variant, intron_variant | Intron 15 of 43 | NP_001191332.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0130 AC: 1728AN: 133068Hom.: 43 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
1728
AN:
133068
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0106 AC: 1204AN: 113098 AF XY: 0.00923 show subpopulations
GnomAD2 exomes
AF:
AC:
1204
AN:
113098
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00576 AC: 6415AN: 1114154Hom.: 8 Cov.: 21 AF XY: 0.00577 AC XY: 3225AN XY: 558592 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
6415
AN:
1114154
Hom.:
Cov.:
21
AF XY:
AC XY:
3225
AN XY:
558592
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1391
AN:
25782
American (AMR)
AF:
AC:
197
AN:
32434
Ashkenazi Jewish (ASJ)
AF:
AC:
63
AN:
20798
East Asian (EAS)
AF:
AC:
169
AN:
33158
South Asian (SAS)
AF:
AC:
501
AN:
66432
European-Finnish (FIN)
AF:
AC:
80
AN:
36938
Middle Eastern (MID)
AF:
AC:
32
AN:
4630
European-Non Finnish (NFE)
AF:
AC:
3607
AN:
847342
Other (OTH)
AF:
AC:
375
AN:
46640
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.307
Heterozygous variant carriers
0
454
907
1361
1814
2268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0130 AC: 1728AN: 133102Hom.: 43 Cov.: 28 AF XY: 0.0127 AC XY: 814AN XY: 63854 show subpopulations
GnomAD4 genome
AF:
AC:
1728
AN:
133102
Hom.:
Cov.:
28
AF XY:
AC XY:
814
AN XY:
63854
show subpopulations
African (AFR)
AF:
AC:
1609
AN:
37128
American (AMR)
AF:
AC:
67
AN:
13046
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3192
East Asian (EAS)
AF:
AC:
7
AN:
4680
South Asian (SAS)
AF:
AC:
6
AN:
4208
European-Finnish (FIN)
AF:
AC:
1
AN:
7022
Middle Eastern (MID)
AF:
AC:
0
AN:
268
European-Non Finnish (NFE)
AF:
AC:
15
AN:
60986
Other (OTH)
AF:
AC:
21
AN:
1790
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
79
157
236
314
393
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Sep 23, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Intellectual disability-hypotonia-spasticity-sleep disorder syndrome Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.